A REVIEW OF JWH-018 POWDER

As an entire agonist at each the CB1 and CB2 cannabinoid receptors, this chemical compound is assessed as an analgesic medication. The analgesic results of cannabinoid ligands, mediated by CB1 receptors are very well established in treatment of neuropathic discomfort, and also most cancers suffering and arthritis.This product is often a DEA exempt